NCT06007937 2026-02-05
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Recruiting
Memorial Sloan Kettering Cancer Center
Hunan Province Tumor Hospital
Hunan Province Tumor Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS